Loading clinical trials...

UNKNOWNNA

Application of the Web-based Acceptance and Commitment Therapy for Depression

The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients with Major Depressive Disorder

NCT06293781•Gachon University

View on ClinicalTrials.gov

Summary

PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY

Detailed Description

Acceptance Commitment Therapy (ACT) is known to help people recover from depression by improving psychological flexibility through acceptance, defusion, self-as-context, present moment, committed action, and helping them live a values-based life. This study is a randomized controlled trial to determine if web-based ACT leads to changes in the psychological flexibility and cognitive fusion. Also, through the functional MRI study, possible treatment mechanisms by which the web-based ACT exerts will be identified.

Eligibility

Age

19 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients who diagnosed major depressive disorder

Exclusion Criteria

•Patients who have serious medical problems, metal implants in their bodies, severe brain injury or brain disease
•Women who were pregnant or nursing
•Patients at high risk for suicide

Locations (1)

Kyoung-Sae Na

Incheon, Please Incheon, South Korea

Key Dates

Start Date

December 19, 2022

Primary Completion Date

February 28, 2025

Completion Date

February 28, 2025

Last Updated

October 16, 2024

Enrollment

ESTIMATED participants

Conditions

Major Depressive Disorder

Interventions

Web-based ACT

DEVICE

Treatment as usual

BEHAVIORAL

Contacts

Kyoung-Sae Na, MD, PhD

CONTACT

82324689932 ksna13@gmail.com

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

NCT07115329

Major Depressive Disorder

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 16, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Application of the Web-based Acceptance and Commitment Therapy for Depression

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment

University of Iowa Interventional Psychiatry Service Patient Registry

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)